Uganda:My Five Minutes in New Cancer Machine
[Observer] Angella Kemirembe, 39, a resident of Kawempe, was among the first cancer patients to undergo treatment using Uganda's newly commissioned and only Cobalt 60 radiotherapy machine recently. She had been diagnosed with cervical cancer in 2016. This is part of her story about the treatment. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 6, 2018 Category: African Health Source Type: news
Uganda:Cancer Cases Rise As Govt Launches New Machine
[Monitor] Kampala -As government commissions the new Cobalt 60 radiotherapy machines today, the Uganda Cancer Institute (UCI) has revealed that the number of new cancer cases registered annually has shot up by 500, rising from 4,000 in 2016 to 4,500 in 2017. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 19, 2018 Category: African Health Source Type: news
Research may improve artificial joints used in hip replacement surgery
(Wiley) A new Journal of Orthopaedic Research study that examined artificial joints used for total hip replacement found that ceramic components may experience less corrosion than cobalt-chromium components. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 10, 2018 Category: International Medicine & Public Health Source Type: news
FDA clears Xcision Medical ’ s GammaPod breast cancer device
The FDA said today that it granted 510(k) clearance to the GammaPod stereotactic radiotherapy device made by Xcision Medical Systems to treat breast cancer.
The federal safety watchdog said the GammaPod is designed to treat a portion of the breast in conjunction with breast-conserving surgery. It uses an array of 36 Cobalt-60 sources to beam radiation from within a two-layer vacuum cup that immobilizes the breast to minimize damage to adjacent healthy tissue.
GammaPod is not intended to replace whole-breast radiation therapy and has not been shown to be as effective as that technique, the FDA said. The clearance was based...
Source: Mass Device - December 22, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Radiosurgery Regulatory/Compliance xcisionmedicalsystems Source Type: news
2D nanofluidic channels improve electrochemical energy storage
Nano-architectures based on cobalt oxide could make superior lithium-ion battery electrodes. (Source: Nanotechweb.org News)
Source: Nanotechweb.org News - December 14, 2017 Category: Nanotechnology Authors: Belle Dum é Source Type: news
Synthesis of ultrasmall, homogeneously alloyed, bimetallic nanoparticles on silica supports
Supported nanoparticles containing more than one metal have a variety of applications in sensing, catalysis, and biomedicine. Common synthesis techniques for this type of material often result in large, unalloyed nanoparticles that lack the interactions between the two metals that give the particles their desired characteristics. We demonstrate a relatively simple, effective, generalizable method to produce highly dispersed, well-alloyed bimetallic nanoparticles. Ten permutations of noble and base metals (platinum, palladium, copper, nickel, and cobalt) were synthesized with average particle sizes from 0.9 to 1.4 nanometer...
Source: ScienceNOW - December 14, 2017 Category: Science Authors: Wong, A., Liu, Q., Griffin, S., Nicholls, A., Regalbuto, J. R. Tags: Chemistry, Physics reports Source Type: news
Uganda:Cancer Institute to Resume Radiotherapy Treatment
[Monitor] Cancer patients will start accessing radiotherapy treatment effective next month when the testing of the new cobalt 60 machine is expected to be completed, the executive director of Uganda Cancer Institute (UCI) has said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 23, 2017 Category: African Health Source Type: news
Uganda:New Cancer Machine Starts Work in December
[Observer] The executive director of Uganda Cancer Institute (UCI), Dr Jackson Orem, has assured the public that the new Cobalt 60 radiotherapy machine will be pressed into service by mid-December, raising the hopes of many long-suffering patients. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 22, 2017 Category: African Health Source Type: news
Cordis Comes Back for Another Stent
Cordis is getting back into the coronary stent game. The company, which is now owned by Cardinal Health, landed exclusive rights to sell Medinol's coronary stent portfolio in the U.S.
Milpitas, CA-based Cordis is already selling Medinol's NIRxcell cobalt-chromium bare-metal stent and, assuming FDA approves Medinol's EluNIR drug-eluting stent (DES), Cordis will distribute it as well. Medinol is based in Israel.
In addition to the Medinol agreement, Cordis recently launched the Tryton Side Branch Stent and two percutaneous transluminal coronary angioplasty (PTCA) balloon catheters. The Medinol agreement, along with the avai...
Source: MDDI - October 31, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Source Type: news
Cordis inks exclusive distribution deal for Medinol ’ s coronary stent portfolio in US
Cordis has inked an exclusive distribution deal to sell Medinol‘s coronary stents in the U.S., the company reported, adding a cobalt-chromium bare-metal stent and a drug-eluting stent to its portfolio.
According to the deal, Cordis plans to start selling Medinol’s NIRxcell BMS immediately and will exclusively distribute the company’s EluNir drug-eluting stent if it wins FDA approval.
Get the full story at our sister site, Drug Delivery Business News.
The post Cordis inks exclusive distribution deal for Medinol’s coronary stent portfolio in US appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - October 30, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Drug-Device Combinations Drug-Eluting Stents Pharmaceuticals Cordis Corp. Medinol Ltd Source Type: news
Cobalt and tungsten -- the key to cheaper, cleaner hydrogen
(Institute of Chemical Research of Catalonia (ICIQ)) Researchers at the Institute of Chemical Research of Catalonia (ICIQ) and Rovira and Virgili University (URV, both in Tarragona, Spain) presented their results in the prestigious scientific journal 'Nature Chemistry'. The new catalyst features cobalt and tungsten, Earth-abundant materials that are way cheaper than current alternatives, based in precious metals like iridium. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 30, 2017 Category: Biology Source Type: news
MOF-derived cobalt nanoparticles catalyze a general synthesis of amines
The development of base metal catalysts for the synthesis of pharmaceutically relevant compounds remains an important goal of chemical research. Here, we report that cobalt nanoparticles encapsulated by a graphitic shell are broadly effective reductive amination catalysts. Their convenient and practical preparation entailed template assembly of cobalt-diamine-dicarboxylic acid metal organic frameworks on carbon and subsequent pyrolysis under inert atmosphere. The resulting stable and reusable catalysts were active for synthesis of primary, secondary, tertiary, and N-methylamines (more than 140 examples). The reaction coupl...
Source: ScienceNOW - October 19, 2017 Category: Science Authors: Jagadeesh, R. V., Murugesan, K., Alshammari, A. S., Neumann, H., Pohl, M.-M., Radnik, J., Beller, M. Tags: Chemistry r-articles Source Type: news
AMRI ’s SSCI Adds Cobalt Light Systems Transmission Raman Spectrometer...
Further enhances solid state characterization and method development capabilities and is uniquely suited for applications requiring acquisition of a large number of spectra for both quantitative or...(PRWeb October 18, 2017)Read the full story at http://www.prweb.com/releases/2017/10/prweb14803856.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 18, 2017 Category: Pharmaceuticals Source Type: news
The Dark Side of Electric Cars: Exploitative Labor Practices
The Scottish government recently announced plans to, by 2032, phase out petrol and diesel vehicles. By 2040, the only cars on United Kingdom roads will also be electric, and petrol stations will be replaced by car charging points. Meanwhile, in the United States, Elon Musk has announced the launch of the Tesla Model 3, which he hopes will become the world’s first mass-market electric car.
This shift to green technology is extremely welcome. Climate change is one of the biggest human rights challenges of our time, and cities from London to Delhi are choking on vehicle fumes. The move to electric cars will improve air ...
Source: TIME.com: Top Science and Health Stories - September 28, 2017 Category: Consumer Health News Authors: Mark Dummett Tags: Uncategorized technology world affairs Source Type: news
Cobalt nanoparticles for making amines cheaply and simply
New catalyst could compete with those based on precious metals for the industrially important reductive amination reaction. (Source: Nanotechweb.org News)
Source: Nanotechweb.org News - September 25, 2017 Category: Nanotechnology Authors: Belle Dum é Source Type: news
